FDA names drugmakers accused of blocking cheaper generics - WTOC-TV: Savannah, Beaufort, SC, News, Weather & Sports

FDA names drugmakers accused of blocking cheaper generics

(AP Photo/Andrew Harnik, File). FILE- In this Oct. 14, 2015, the Food & Drug Administration (FDA) campus in Silver Spring, Md. U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call “gaming... (AP Photo/Andrew Harnik, File). FILE- In this Oct. 14, 2015, the Food & Drug Administration (FDA) campus in Silver Spring, Md. U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call “gaming...

By LINDA A. JOHNSON
AP Medical Writer

TRENTON, N.J. (AP) - U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.

The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, many carrying five- or six-figure annual price tags, who are under scrutiny. The agency also lists inquiries it has received from generic drugmakers requesting FDA's help in getting access to the brand-name drugs though not all the complaints have been verified.

Generic drug companies generally require 1,000 to 1,500 units, such as pills, of a brand-name drug to create much-cheaper drugs with identical active ingredients and effects. The FDA said Thursday that brand-name drugmakers sometimes refuse to sell generic companies drugs that may need extra safety monitoring or bar drug wholesalers from selling other medicines to generic drugmakers.

"We hope that this increased transparency will help reduce unnecessary hurdles to generic drug development and approval," the FDA said in a statement.

Delayed launches of generic versions of drugs whose patents have expired usually push higher costs onto patients, employers and taxpayers.

One drugmaker strategy - a limited distribution network in which the company only provides its medicine to one or two wholesalers or pharmacies instead of many distributors - enables the maker to better control and raise prices. That's how former Turing Pharmaceuticals CEO Martin Shkreli was able to hike the price of a 60-year-old anti-infective drug, Daraprim, from $13.50 to $750 per pill.

Several of the world's largest drugmakers were cited by FDA as having refused to sell more than one medicine to generic companies, often drugs long on the market that generate billions in annual sales. Those include Switzerland's Novartis AG, cited for blocking access to four medicines, and Summit, New Jersey-based Celgene Corp., cited for blocking access to three drugs.

Many of the drugs are for various cancers, HIV and heart disease.

Novartis said in a statement that it "disagrees with the inclusion of our products on the list." The company said its drugs on the list have a generic version under FDA review.

Celgene said generic versions of some of its drugs will reach the market "in coming years." But the drugmaker said there needs to be a better process to ensure the safety of generic versions on the market since its three drugs on the list carries serious risks including birth defects.

Celgene is accused of using a second strategy for blocking generics that FDA also is targeting. It involves riskier-than-average drugs that fall under an FDA program intended to limit use to patients most likely to benefit, who are urged to take precautions such as preventing pregnancy.

The FDA said in some cases brand-name companies have improperly used that as a reason to refuse to sell samples to generic drugmakers.

That tactic costs patients, insurers and government programs more than $6 billion annually, according to a trade group for generic drugmakers.

___

Follow Linda A. Johnson on Twitter: LindaJ_onPharma

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • NationalMore>>

  • More LGBT issues loom as justices near wedding cake decision

    More LGBT issues loom as justices near wedding cake decision

    Saturday, May 26 2018 9:33 AM EDT2018-05-26 13:33:35 GMT
    Monday, May 28 2018 4:07 AM EDT2018-05-28 08:07:12 GMT
    (AP Photo/J. Scott Applewhite, File). FILE - In this Oct. 10, 2017, file photo, the Supreme Court in Washington is seen at sunset. A flood of lawsuits over LGBT rights is making its way through the courts and will continue, no matter the outcome in the...(AP Photo/J. Scott Applewhite, File). FILE - In this Oct. 10, 2017, file photo, the Supreme Court in Washington is seen at sunset. A flood of lawsuits over LGBT rights is making its way through the courts and will continue, no matter the outcome in the...

    A flood of lawsuits over LGBT rights is making its way through courts and that'll continue, no matter what the Supreme Court decides in the case of a baker who wouldn't create a wedding cake for a same-sex couple.

    More >>

    A flood of lawsuits over LGBT rights is making its way through courts and that'll continue, no matter what the Supreme Court decides in the case of a baker who wouldn't create a wedding cake for a same-sex couple.

    More >>
  • Bloody but forgotten WWII battle still haunts soldiers

    Bloody but forgotten WWII battle still haunts soldiers

    Sunday, May 27 2018 11:34 AM EDT2018-05-27 15:34:09 GMT
    Monday, May 28 2018 4:05 AM EDT2018-05-28 08:05:04 GMT
    (AP Photo/Mark Thiessen). In this May 19, 2018, photo World War II veterans Allan Seroll, left, of Massachusetts, and William Roy Dover, right, of Alabama, right, attend a 75th anniversary celebration of the Battle of Attu in Anchorage, Alaska. Dover w...(AP Photo/Mark Thiessen). In this May 19, 2018, photo World War II veterans Allan Seroll, left, of Massachusetts, and William Roy Dover, right, of Alabama, right, attend a 75th anniversary celebration of the Battle of Attu in Anchorage, Alaska. Dover w...

    One of the bloodiest World War II battles in the Pacific was waged 75 years ago this month on Attu Island in Alaska's Aleutian Islands.

    More >>

    One of the bloodiest World War II battles in the Pacific was waged 75 years ago this month on Attu Island in Alaska's Aleutian Islands.

    More >>
  • 'Solo' sputters in takeoff with $83.3M at box office

    'Solo' sputters in takeoff with $83.3M at box office

    Sunday, May 27 2018 11:54 AM EDT2018-05-27 15:54:44 GMT
    Monday, May 28 2018 3:44 AM EDT2018-05-28 07:44:49 GMT
    (Jonathan Olley/Lucasfilm via AP). In this image released by Lucasfilm, Alden Ehrenreich, right, and Joonas Suotamo appear in a scene from "Solo: A Star Wars Story."(Jonathan Olley/Lucasfilm via AP). In this image released by Lucasfilm, Alden Ehrenreich, right, and Joonas Suotamo appear in a scene from "Solo: A Star Wars Story."
    The Han Solo spinoff "Solo: A Star Wars Story" came in well below expectations with an $83.3 million opening weekend at the North American box office.More >>
    The Han Solo spinoff "Solo: A Star Wars Story" came in well below expectations with an $83.3 million opening weekend at the North American box office.More >>
Powered by Frankly